AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteAzacyclonol, also known as ??-pipradol, is a drug used to diminish hallucinations in psychotic individuals.
More Information Supplier PageAzacyclonol, also known as ??-pipradol, is a drug used to diminish hallucinations in psychotic individuals.
More Information Supplier PageAzacyclonol, also known as ??-pipradol, is a drug used to diminish hallucinations in psychotic individuals.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzafen is a tricyclic antidepressant.It acts as a potent inhibitor of the reuptake of serotonin.
More Information Supplier PageAzafen is a tricyclic antidepressant.It acts as a potent inhibitor of the reuptake of serotonin.
More Information Supplier PageAzafen is a tricyclic antidepressant.It acts as a potent inhibitor of the reuptake of serotonin.
More Information Supplier PageAzafen is a tricyclic antidepressant.It acts as a potent inhibitor of the reuptake of serotonin.
More Information Supplier PageAzathioprine inhibits an enzyme that is required for the synthesis of DNA, thus most strongly affects proliferating cells, such as the T cells and B cells of the immune system.
More Information Supplier PageAzathioprine inhibits an enzyme that is required for the synthesis of DNA, thus most strongly affects proliferating cells, such as the T cells and B cells of the immune system.
More Information Supplier PageAzathioprine inhibits an enzyme that is required for the synthesis of DNA, thus most strongly affects proliferating cells, such as the T cells and B cells of the immune system.
More Information Supplier PageAzathioprine inhibits an enzyme that is required for the synthesis of DNA, thus most strongly affects proliferating cells, such as the T cells and B cells of the immune system.
More Information Supplier PageAzathioprine inhibits an enzyme that is required for the synthesis of DNA, thus most strongly affects proliferating cells, such as the T cells and B cells of the immune system.
More Information Supplier PageAzithromycin, derived from erythromycin, is a antibiotic. Azithromycin binds to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA.
More Information Supplier PageAzithromycin, derived from erythromycin, is a antibiotic. Azithromycin binds to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA.
More Information Supplier PageAzithromycin, derived from erythromycin, is a antibiotic. Azithromycin binds to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA.
More Information Supplier PageAZD2461 is a novel and potent PARP inhibitor with lower affinity to P-glycoprotein.
More Information Supplier PageAZD2461 is a novel and potent PARP inhibitor with lower affinity to P-glycoprotein.
More Information Supplier PageAZD2461 is a novel and potent PARP inhibitor with lower affinity to P-glycoprotein.
More Information Supplier PageAZD2461 is a novel and potent PARP inhibitor with lower affinity to P-glycoprotein.
More Information Supplier PageAZD2461 is a novel and potent PARP inhibitor with lower affinity to P-glycoprotein.
More Information Supplier PageAZD3965 is a selective inhibitor of monocarboxylate transporter 1 (MCT1) with a binding affinity of 1.6 nM, is 6 fold selective over MCT2 and does not inhibit MCT4 at 10 ??M.
More Information Supplier PageAZD3965 is a selective inhibitor of monocarboxylate transporter 1 (MCT1) with a binding affinity of 1.6 nM, is 6 fold selective over MCT2 and does not inhibit MCT4 at 10 ??M.
More Information Supplier PageAZD3965 is a selective inhibitor of monocarboxylate transporter 1 (MCT1) with a binding affinity of 1.6 nM, is 6 fold selective over MCT2 and does not inhibit MCT4 at 10 ??M.
More Information Supplier PageAZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors.
More Information Supplier PageAZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors.
More Information Supplier PageAZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors.
More Information Supplier PageAZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors.
More Information Supplier PageAZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors.
More Information Supplier PageAZD1080 is a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
More Information Supplier PageAZD1080 is a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
More Information Supplier PageAZD1080 is a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
More Information Supplier PageAZD1080 is a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
More Information Supplier PageAZD1080 is a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
More Information Supplier PageAZD1152 is a pro-drug that rapidly undergoes phosphatase-mediated cleavage in serum to release barasertib-hQPA, a selective Aurora B kinase inhibitor that has shown preliminary activity in clinical studies of patients with acute myeloid leukemia (AML).
More Information Supplier PageAZD1152 is a pro-drug that rapidly undergoes phosphatase-mediated cleavage in serum to release barasertib-hQPA, a selective Aurora B kinase inhibitor that has shown preliminary activity in clinical studies of patients with acute myeloid leukemia (AML).
More Information Supplier PageAZD1152 is a pro-drug that rapidly undergoes phosphatase-mediated cleavage in serum to release barasertib-hQPA, a selective Aurora B kinase inhibitor that has shown preliminary activity in clinical studies of patients with acute myeloid leukemia (AML).
More Information Supplier Page
